In addition, TPPU pretreatment of primary human lung fibroblasts from IPF patients significantly dampened TGF-β1-mediated fibroblast activation by suppressing expression of type I collagen (Kim et al. 2021). Here, TGFB1 is linked to idiopathic pulmonary fibrosis.